<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-F1DB25WT</identifier><date>2021</date><creator>Azarija, Jelena</creator><creator>Grašič-Kuhar, Cvetka</creator><creator>Plavc, Gaber</creator><creator>Strojan, Primož</creator><relation>documents/doc/F/URN_NBN_SI_doc-F1DB25WT_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-F1DB25WT_001.txt</relation><format format_type="issue">1</format><format format_type="volume">25</format><format format_type="type">article</format><format format_type="extent">str. 6-11</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">66137859</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-F1DB25WT</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">head and neck cancer</subject><subject language_type_id="eng">immunotherapy</subject><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">nivolumab</subject><subject language_type_id="slv">rak glave in vratu</subject><title>Immunotherapy for squamous cell carcinoma of the head and neck - experience from Slovenia</title><title>Imunoterapija pri ploščatoceličnem karcinomu glave in vratu - izkušnje iz Slovenije</title></Record>